Clinical Research Directory
Browse clinical research sites, groups, and studies.
Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes
Sponsor: VA Office of Research and Development
Summary
More than 25% of the patients admitted in the general wards have a history of Diabetes Mellitus (DM). Up to 30% of the hospitalized diabetics develop hypoglycemia (low glucose values); a condition that is associated with seizures, cardiac arrhythmias, and even death. In Veterans, the prevalence is disproportionally higher. It is estimated that 40-50% of hospitalized Veterans are diabetics. In this clinical trial the investigators describe the development of a novel system, the Glucose Telemetry System (GTS), with which glucose values can be wirelessly transmitted from the patient's bedside to a monitor device at the nursing station. The goal of this work is to develop a more effective glucose surveillance system at the general wards, which can decrease hypoglycemia in the hospital and improve clinical outcomes.
Official title: Continuous Glucose Monitoring in Insulin Treated Hospitalized Veterans With DM2 at Higher Risk for Hypoglycemia
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
218
Start Date
2018-07-01
Completion Date
2026-04-30
Last Updated
2026-01-07
Healthy Volunteers
No
Conditions
Interventions
GTS (Continuous Glucose Monitoring)
Hospitalized patients with DM2 will be monitored with Glucose Telemetry System (GTS)
POC (Point of Care)
Hospitalized patients with DM2 will be monitored with POC (Point of Care) blood glucose levels.
Locations (1)
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, United States